The Crohn's disease protein, NOD2, requires RIP2 in order to induce ubiquitinylation of a novel site on NEMO

Current Biology

Volumn 14, Issue 24, 2004, Pages 2217-2227

  Abbott, Derek W ^a,b,c   Wilkins, Andrew ^b   Asara, John M ^b   Cantley, Lewis C ^b,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARD15 PROTEIN, HUMAN; CARRIER PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; I KAPPA B KINASE; IKBKG PROTEIN, HUMAN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; RECEPTOR INTERACTING PROTEIN SERINE THREONINE KINASE 2; RIPK2 PROTEIN, HUMAN; SIGNAL PEPTIDE; UBIQUITIN;

AMINO ACID SEQUENCE; ARTICLE; CELL CULTURE; COMPARATIVE STUDY; CROHN DISEASE; GENETIC POLYMORPHISM; GENETICS; HUMAN; IMMUNOPRECIPITATION; MASS SPECTROMETRY; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; BLOTTING, WESTERN; CARRIER PROTEINS; CELLS, CULTURED; CROHN DISEASE; HUMANS; I-KAPPA B KINASE; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; NF-KAPPA B; NOD2 SIGNALING ADAPTOR PROTEIN; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTOR-INTERACTING PROTEIN SERINE-THREONINE KINASE 2; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; UBIQUITIN;

EID: 11144289688     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2004.12.032     Document Type: Article

References (39)

1. Bouma G., Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3:2003;521-533
2. Podolsky D.K. Inflammatory bowel disease. N. Engl. J. Med. 8:2002;417-429
3. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H., et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:2001;603-606
4. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M., et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603
5. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276:2001;4812-4818
6. Beutler B. Autoimmunity and apoptosis. The Crohn's connection Immunity. 15:2001;5-14
7. Inohara N., Ogura Y., Chen F.F., Muto A., Nunez G. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276:2001;2551-2554
8. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:2003;8869-8872
9. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M., et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278:2003;5509-5512
10. Kobayashi K.S., Eynon E.E., Flavell R.A. Intracellular debugging. Nat. Immunol. 4:2003;652-654
11. Inohara N., Koseki T., Lin J., del Peso P.C., Lucas F.F., Chen Y., Ogura Y., Nunez G. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275:2000;27823-27831
12. Chamaillard M., Philpott D., Girardin S.E., Zouali H., Lesage S., Chareyre F., Bui T.H., Giovannini M., Zaehringer U., Penard-Lacronique V., et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. USA. 100:2003;3455-3460
13. Ellis R.D., Goodlad J.R., Limb G.A., Powell J.J., Thompson R.P., Punchard N.A. Activation of nuclear factor kappa B in Crohn's disease. Inflamm. Res. 47:1998;440-445
14. Rogler G., Brand K., Vogl D., Page S., Hofmeister R., Andus T., Knuechel R., Baeuerle P.A., Scholmerich J., Gross V. Nuclear factor kappaB is activated in macrophages and epithelial cells of inflamed intestinal mucosa. Gastroenterology. 115:1998;357-369
15. Watanabe T., Kitani A., Murray P.J., Strober W. NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5:2004;800-808
16. O'Neill L.A.J. How NOD-ing off leads to Crohn disease. Nat. Immunol. 5:2004;776-778
17. Kobayashi K., Inohara N., Hernandez L.D., Galan J.E., Nunez G., Janeway C.A., Medzhitov R., Flavell R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 416:2002;194-199
18. Inohara N., del Peso L., Koseki T., Chen S., Nunez G. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273:1998;12296-12300
19. McCarthy J.V., Ni J., Dixit V.M. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J. Biol. Chem. 273:1998;16968-16975
20. Thome M., Hofmann K., Burns K., Martinon F., Bodmer J.L., Mattmann C., Tschopp J. Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 8:1998;885-888
21. Zhou H., Wertz I., O'Rourke K., Ultsch M., Seshagiri S., Eby M., Xiao W., Dixit V.M. Bcl10 activates the NF-kappaB pathway through ubiquitination of NEMO. Nature. 424:2004;167-171
22. Sun L., Deng L., Ea C.K., Xia Z.P., Chen Z.J. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell. 7:2004;289-301
23. Tang E.D., Wang C.Y., Xiong Y., Guan K.L. A role for NF-kappaB essential modifier/IkappaB kinase-gamma (NEMO/IKKgamma) ubiquitination in the activation of the IkappaB kinase complex by tumor necrosis factor-alpha. J. Biol. Chem. 278:2003;37297-37305
24. Schnell J.D., Hicke L. Non-traditional functions of ubiquitin and ubiquitin-binding proteins. J. Biol. Chem. 278:2003;35857-35860
25. Morris J.R., Solomon E. BRCA1. BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during dna replication and repair Hum. Mol. Genet. 13:2004;807-817
26. Kanayama A., Seth R.B., Sun L., Ea C.K., Hong M., Shaito A., Chiu Y.H., Deng L., Chen Z.J. TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains. Mol. Cell. 15:2004;535-548
27. Gutierrez O., Pipaon C., Inohara N., Fontalba A., Ogura Y., Prosper F., Nunez G., Fernandez-Luna J.L. Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-kappa B activation. J. Biol. Chem. 277:2002;41701-41705
28. Tanabe T., Chamaillard M., Ogura Y., Zhu L., Qiu S., Masumoto J., Ghosh P., Moran A., Predergast M.M., Tromp G., et al. Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 23:2004;1587-1597
29. Peng J., Schwartz D., Elias J.E., Thoreen C.C., Cheng D., Marsischky G., Roelofs J., Finley D., Gygi S.P. A proteomics approach to understanding protein ubiquitination. Nat. Biotechnol. 21:2003;921-926
30. Li Y., Kang J., Friedman J., Tarassishin L., Ye J., Kovalenko A., Wallach D., Horwitz M.S. Identification of a cell protein (FIP-3) as a modulator of NF-kappaB activity and as a target of an adenovirus inhibitor of tumor necrosis factor alpha-induced apoptosis. Proc. Natl. Acad. Sci. USA. 96:1999;1042-1047
31. Yamaoka S., Courtois G., Bessia C., Whiteside S.T., Weil R., Agou F., Kirk H.E., Kay R.J., Israel A. Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 93:1998;1231-1240
32. Rothwarf D.M., Zandi E., Natoli G., Karin M. IKKγ is an essential regulatory subunit of the IB kinase complex. Nature. 395:1998;297-300
33. Bignell G.R., Warren W., Seal S., Takahashi M., Rapley E., Barfoot R., Green H., Brown C., Biggs P.J., Lakhani S.R., et al. Identification of the familial cylindromatosis tumour-suppressor gene. Nat. Genet. 25:2000;160-165
34. Kovalenko A., Chable-Bessia C., Cantarella G., Israel A., Wallach D., Courtois G. The tumour suppressor CYLD negatively regulates NF-kappaB signalling by deubiquitination. Nature. 424:2003;801-805
35. Brummelkamp T.R., Nijman S.M., Dirac A.M., Bernards R. Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature. 424:2003;797-801
36. Trompouki E., Hatzivassiliou E., Tsichritzis T., Farmer H., Ashworth A., Mosialos G. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature. 424:2003;793-796
37. Delhase M., Hayakawa M., Chen Y., Karin M. Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science. 284:1999;309-313
38. Wertz I.E., O'Rourke K.M., Zhou H., Eby M., Aravind L., Seshagiri S., Wu P., Wiesmann C., Baker R., Boone D.L., et al. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature. 430:2004;694-699
39. Abbott D.W., Holt J.T. Mitogen-activated protein kinase kinase 2 activation is essential for progression through the G2/M checkpoint arrest in cells exposed to ionizing radiation. J. Biol. Chem. 29:1999;2732-2742